Illumina (GB:0J8Z)
UK Market

Illumina Stock Analysis & Ratings

GB:0J8Z Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$243.04
Average Volume (3M)1.67K
Market Cap$38.18B
P/E Ratio53.0
Next EarningsAug 01, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score7
EPS (TTM)4.58



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Illumina’s price range in the past 12 months?
Illumina lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Illumina’s market cap?
    Illumina’s market cap is $38.18B.
      What is Illumina’s price target?
      The average price target for Illumina is $374.92. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $520.00 ,the lowest forecast is $280.00. The average price target represents 54.26% Increase from the current price of $243.04.
        What do analysts say about Illumina?
        Illumina’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
          When is Illumina’s upcoming earnings report date?
          Illumina’s upcoming earnings report date is Aug 01, 2022 which is in 75 days.
            How were Illumina’s earnings last quarter?
            Illumina released its earnings results on May 05, 2022. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.897 by $0.173.
              Is Illumina overvalued?
              According to Wall Street analysts Illumina’s price is currently Undervalued.
                Does Illumina pay dividends?
                Illumina does not currently pay dividends.
                What is Illumina’s EPS estimate?
                Illumina’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Illumina have?
                Illumina has 157,100,000 shares outstanding.
                  What happened to Illumina’s price movement after its last earnings report?
                  Illumina reported an EPS of $1.07 in its last earnings report, beating expectations of $0.897. Following the earnings report the stock price went down -17.154%.
                    Which hedge fund is a major shareholder of Illumina?
                    Among the largest hedge funds holding Illumina’s share is Guardcap Asset Management Ltd. It holds Illumina’s shares valued at 477M.


                      Illumina Stock Analysis

                      The Illumina stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description


                      Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.

                      Similar Stocks
                      Price & Change
                      HTG Molecular Diagnostics
                      Bio-Rad Laboratories
                      Pacific Biosciences

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis